You are here

Updates to the Prescribing Medicines in Pregnancy database

15 April 2021

Prescribing Medicines in Pregnancy database has been updated to include the following new entries:

  • afamelanotide - pregnancy category B1
  • cannabidiol - pregnancy category B2
  • cariprazine - pregnancy category D
  • COVID-19 Vaccine - BNT162b2 (mRNA) - pregnancy category B1
  • COVID-19 Vaccine - ChAdOx1-S - pregnancy category B2
  • gemtuzumab ozogamicin - pregnancy category D
  • larotrectinib - pregnancy category D
  • mogamulizumab - pregnancy category C
  • niraparib - pregnancy category D
  • onasemnogene abeparvovec - pregnancy category B2
  • opicapone - pregnancy category B2
  • romosozumab - pregnancy category B3
  • satralizumab - pregnancy category C
  • tafamidis - pregnancy category D
  • trientine - pregnancy category D
  • trifarotene - pregnancy category D

The following entries have been amended:

  • betamethasone dipropionate - pregnancy category changed from B1 to B3
  • betamethasone dipropionate / calcipotriol - pregnancy category changed from B1 to B3
  • griseofulvin - pregnancy category changed from B3 to D
  • diphtheria-tetanus-pertussis vaccine - pregnancy category changed from B2 to A